Global Vaccines Market Growth 2025-2031

The global Vaccines market size is predicted to grow from US$ 49350 million in 2025 to US$ 69260 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.

LP Information, Inc. (LPI) ' newest research report, the “Vaccines Industry Forecast” looks at past sales and reviews total world Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Vaccines sales for 2025 through 2031. With Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccines.

This report presents a comprehensive overview, market shares, and growth opportunities of Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others

Segmentation by Application:
Rabies vaccine
Influenza vaccine
HPV vaccine
Hepatitis B
Hepatitis A
Leprosy vaccine
Polio vaccine
JE vaccine
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan

Key Questions Addressed in this Report

What is the 10-year outlook for the global Vaccines market?

What factors are driving Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Vaccines market opportunities vary by end market size?

How does Vaccines break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.